Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) EBITDA (2017 - 2026)

Neuronetics has reported EBITDA over the past 10 years, most recently at -$9.0 million for Q1 2026.

  • Quarterly EBITDA rose 18.33% to -$9.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$29.4 million through Mar 2026, up 24.03% year-over-year, with the annual reading at -$31.4 million for FY2025, 9.05% up from the prior year.
  • EBITDA was -$9.0 million for Q1 2026 at Neuronetics, down from -$5.0 million in the prior quarter.
  • Over five years, EBITDA peaked at -$4.4 million in Q4 2023 and troughed at -$11.5 million in Q4 2024.
  • The 5-year median for EBITDA is -$8.1 million (2025), against an average of -$8.3 million.
  • Year-over-year, EBITDA plummeted 159.14% in 2024 and then surged 56.04% in 2025.
  • A 5-year view of EBITDA shows it stood at -$7.7 million in 2022, then skyrocketed by 42.71% to -$4.4 million in 2023, then plummeted by 159.14% to -$11.5 million in 2024, then surged by 56.04% to -$5.0 million in 2025, then plummeted by 78.37% to -$9.0 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's EBITDA are -$9.0 million (Q1 2026), -$5.0 million (Q4 2025), and -$7.3 million (Q3 2025).